SAH (Subarachnoid Hemorrhage) Clinical Trial
Official title:
Cerebrolysin in Patients Diagnosed With SAH - an Observational Cohort Study (PILOT)
Subarachnoid haemorrhage often affects people in middle age and is associated with high mortality or neurological damage. In recent years, advances in surgical techniques have im-proved the mortality rate. However, there is still need for the research for the optimal possible final effect of treatment. In our study, we've decided to examine the effect of a multimodal approach including Cerebrolysin in the supportive treatment of patients. We've examined the supply of neuroprotective drugs and neuromonitoring.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02275949 -
Acupuncture for Cerebral Vasospasm After Subarachnoid Hemorrhage
|
N/A |